DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
02 2APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
03 1CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN
04 1CIPLA LIMITED Mumbai IN
05 2NATCO PHARMA LIMITED Hyderabad IN
06 1ORCHID PHARMA LIMITED Chennai IN
07 1PHALANX LABS PRIVATE LIMITED Hyderabad IN
08 1QUIMICA SINTETICA S.A. Alcala De Henares ES
09 2SMS PHARMACEUTICALS LIMITED Hyderabad IN
10 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
11 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
01 11Sumatriptan succinate
02 1Sumatriptan succinate, Alternative synthesis
03 1Sumatriptan succinate, Benzoate route
04 1Sumatriptan succinate, Process II
05 1Sumatriptan succinate, STS
01 1Gabon
02 13India
03 1Spain
01 10Valid
02 5Withdrawn by Holder
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Sumatriptan Succinate, Process II
Certificate Number : CEP 2023-022 - Rev 00
Status : Valid
Issue Date : 2023-10-30
Type : Chemical
Substance Number : 1573
Certificate Number : CEP 2006-193 - Rev 07
Status : Valid
Issue Date : 2023-11-14
Type : Chemical
Substance Number : 1573
Sumatriptan Succinate, Benzoate Route
Certificate Number : CEP 2016-134 - Rev 02
Status : Valid
Issue Date : 2024-08-27
Type : Chemical
Substance Number : 1573
Certificate Number : CEP 2022-292 - Rev 00
Status : Valid
Issue Date : 2024-09-02
Type : Chemical
Substance Number : 1573
Certificate Number : R1-CEP 2003-245 - Rev 03
Status : Valid
Issue Date : 2017-02-14
Type : Chemical
Substance Number : 1573
Certificate Number : R1-CEP 2001-089 - Rev 01
Status : Valid
Issue Date : 2020-05-27
Type : Chemical
Substance Number : 1573
Sumatriptan Succinate, Alternative Synthesis
Certificate Number : R1-CEP 2007-329 - Rev 05
Status : Valid
Issue Date : 2019-09-16
Type : Chemical
Substance Number : 1573
Certificate Number : R1-CEP 2009-139 - Rev 01
Status : Valid
Issue Date : 2018-06-18
Type : Chemical
Substance Number : 1573
Certificate Number : CEP 2009-156 - Rev 03
Status : Valid
Issue Date : 2024-07-22
Type : Chemical
Substance Number : 1573
Certificate Number : CEP 2002-246 - Rev 09
Status : Valid
Issue Date : 2024-07-01
Type : Chemical
Substance Number : 1573
A Sumatriptan Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sumatriptan Succinate, including repackagers and relabelers. The FDA regulates Sumatriptan Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sumatriptan Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sumatriptan Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sumatriptan Succinate supplier is an individual or a company that provides Sumatriptan Succinate active pharmaceutical ingredient (API) or Sumatriptan Succinate finished formulations upon request. The Sumatriptan Succinate suppliers may include Sumatriptan Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Sumatriptan Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sumatriptan Succinate CEP of the European Pharmacopoeia monograph is often referred to as a Sumatriptan Succinate Certificate of Suitability (COS). The purpose of a Sumatriptan Succinate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sumatriptan Succinate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sumatriptan Succinate to their clients by showing that a Sumatriptan Succinate CEP has been issued for it. The manufacturer submits a Sumatriptan Succinate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sumatriptan Succinate CEP holder for the record. Additionally, the data presented in the Sumatriptan Succinate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sumatriptan Succinate DMF.
A Sumatriptan Succinate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sumatriptan Succinate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sumatriptan Succinate suppliers with CEP (COS) on PharmaCompass.
We have 11 companies offering Sumatriptan Succinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
